The Republic of Iceland – Government Debt Management
| Series | RIKV 21 0615 | RIKV 21 0915 | ||||
| Settlement Date | 03/01/2021 | 03/01/2021 | ||||
| Total Amount Allocated (MM) | 12,880 | 4,000 | ||||
| All Bids Awarded At (Price / Simple interest) | 99.678 | / | 1.097 | 99.318 | / | 1.249 |
| Total Number of Bids Received | 13 | 11 | ||||
| Total Amount of All Bids Received (MM) | 17,180 | 6,400 | ||||
| Total Number of Successful Bids | 8 | 8 | ||||
| Number of Bids Allocated in Full | 8 | 7 | ||||
| Lowest Price / Highest Simple Interest Allocated | 99.678 | / | 1.097 | 99.318 | / | 1.249 |
| Highest Price / Lowest Simple Interest Allocated | 99.722 | / | 0.947 | 99.399 | / | 1.099 |
| Lowest Price / Highest Simple Interest Allocated in Full | 99.678 | / | 1.097 | 99.334 | / | 1.219 |
| Weighted Average of Successful Bids (Price/Simple Interest) | 99.683 | / | 1.080 | 99.342 | / | 1.204 |
| Best Bid (Price / Simple Interest) | 99.722 | / | 0.947 | 99.399 | / | 1.099 |
| Worst Bid (Price / Simple Interest) | 99.545 | / | 1.552 | 99.290 | / | 1.300 |
| Weighted Average of All Bids Received (Price / Simple Interest) | 99.680 | / | 1.090 | 99.330 | / | 1.226 |
| Percentage Partial Allocation (Approximate) | 100.00 % | 56.67 % | ||||
| Bid to Cover Ratio | 1.33 | 1.60 | ||||
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Maytronics17.10.2025 15:00:00 CEST | Press release
Dolphin Liberty 600 by Maytronics Named to TIME’s List of the Best Inventions of 2025
Evaxion17.10.2025 14:15:51 CEST | Press release
Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01
WillScot17.10.2025 14:00:00 CEST | Press release
WillScot Closes Amended and Extended Asset-Based Revolving Credit Facility
Novartis Pharma AG17.10.2025 14:00:00 CEST | Press release
Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population
Sanofi Winthrop Industrie17.10.2025 13:05:00 CEST | Press release
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom